drug acts highly selective receptor antagonist development avineuro pharmaceuticals treatment early successfully completed phase iia clinical benefits positive symptoms procognitive effects mid phase iib clinical trials schizophrenia avineuro pharmaceuticals also expressed intention start clinical trials alzheimers disease update drug article relating nervous system stub help wikipedia expanding